Recent VIGL News
- Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference • GlobeNewswire Inc. • 05/08/2024 11:40:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 09:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 09:00:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 09:00:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/07/2024 09:00:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:35:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:20:35 PM
- Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting • GlobeNewswire Inc. • 04/17/2024 08:05:00 PM
- Vigil Neuroscience Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/26/2024 11:05:00 AM
- Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 03/20/2024 11:05:00 AM
- Vigil Announces Upcoming Presentations at 2024 American Academy of Neurology Annual Meeting • GlobeNewswire Inc. • 03/13/2024 11:05:00 AM
- Vigil Neuroscience to Present at Stifel 2024 Virtual CNS Days • GlobeNewswire Inc. • 03/12/2024 11:05:00 AM
- Vigil Announces Oral Presentation on Small Molecule TREM2 Agonist VG-3927 as a Potential Disease-Modifying Therapeutic at AD/PD 2024 • GlobeNewswire Inc. • 03/06/2024 09:25:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 11:08:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 10:50:37 PM
- Vigil Presents Poster on Impacts of Misdiagnosis and Genetic Testing on Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia (ALSP) Patient Journey at ACTRIMS 2024 • GlobeNewswire Inc. • 02/29/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 04:33:16 PM
- Vigil Neuroscience to Present at Guggenheim 6th Annual Biotechnology Conference • GlobeNewswire Inc. • 02/07/2024 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 03:30:33 PM
- Vigil Neuroscience Provides 2023 Year-in-Review and Highlights Upcoming 2024 Milestones • GlobeNewswire Inc. • 01/03/2024 09:30:00 PM
- Vigil Neuroscience to Present at Evercore ISI 6th Annual HealthCONx Conference • GlobeNewswire Inc. • 11/22/2023 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:31:03 PM
- Vigil Neuroscience Reports Positive Interim Data from Phase 2 IGNITE Proof-of-Concept Clinical Trial Evaluating Iluzanebart (VGL101) as a Treatment for ALSP and from Ongoing Natural History Study ILLUMINATE • GlobeNewswire Inc. • 11/16/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 12:30:27 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM